Genistein Modulates Immune Responses and Increases Host Resistance to B16F10 Tumor in Adult Female B6C3F1 Mice
Authors:
Open Access
- 1 December 2001
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 131 (12) , 3251-3258
Abstract
The isoflavone genistein (4,7,4′-trihydroxyisoflavone) is a phytoestrogen found in high levels in soy products that has been associated with decreased incidences of breast and prostate cancers. The potential effects of genistein on the immune system were evaluated in adult female B6C3F1 mice. Groups of mice were exposed to vehicle or genistein by gavage for 28 d. The doses of genistein used were 2, 6 and 20 mg/kg body. Consistent with the chemopreventive effect of genistein, exposure to this compound significantly increased host resistance to B16F10 tumor as reflected by a decrease in the number of lung tumor nodules after tumor cell injection at the middle and high dose levels. Inhibition of B16F10 tumor formation was not due to a direct effect of serum genistein and/or its metabolites on the proliferation of B16F10 tumor cells. When innate and acquired immune responses were evaluated, a dose-related increase of cytotoxic T-cell activity was observed in genistein-treated mice with significant changes observed at the middle and high dose levels. Furthermore, in vitro interleukin (IL)-2–stimulated natural killer (NK) cell activity was significantly enhanced in the high genistein dose group, although the basal NK cell activity was not affected. Although no affect on the mixed lymphocyte responses and anti-CD3 antibody-mediated splenocyte proliferation was observed, exposure to genistein significantly increased basal splenocyte proliferation. Exposure to genistein did not alter the activity of the mononuclear phagocyte system and the cytotoxic/cytostatic function of thioglycollate-recruited peritoneal cells on B16F10 tumor cells. Finally, exposure to genistein did not produce biologically meaningful changes in spleen immunoglobulin (Ig)M and IgG antibody-forming cell responses. In conclusion, genistein enhanced host resistance as evaluated in the B16F10 tumor model, which may be related to the increases in the activities of cytotoxic T cells and NK cells.Keywords
This publication has 35 references indexed in Scilit:
- GLYCIDOL MODULATION OF THE IMMUNE RESPONSES IN FEMALE B6C3F1 MICEDrug and Chemical Toxicology, 2000
- Effect of isoflayones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F‐10 melanoma cellsNutrition and Cancer, 1998
- Enhancement of immune function in mice fed high doses of soy daidzeinNutrition and Cancer, 1997
- Potent Inhibition of Breast Cancer Cell Lines by the Isoflavonoid Kievitone: Comparison with GenisteinBiochemical and Biophysical Research Communications, 1995
- Inhbition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genisteinCancer Letters, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- An immunotoxicological evaluation of 4,4?-thiobis-(6-t-butyl-m-cresol) in female B6C3F1 mice 2. Humoral and cell-mediated immunity, macrophage function, and host resistanceFundamental and Applied Toxicology, 1988
- Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.Journal of Experimental Medicine, 1987
- Affinity of T and B lymphocyte receptors for hapten determinantsEuropean Journal of Immunology, 1973
- ESTROGENIC ACTIVITY OF SOME NATURALLY OCCURRING ISOFLAVONESAnnals of the New York Academy of Sciences, 1955